These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 30110240)
21. The impact of forced degradation conditions on mAb dimer formation and subsequent influence on aggregation propensity. Knight MJ; Floret L; Patel N; O'Hara J; Rodriguez E MAbs; 2022; 14(1):2127172. PubMed ID: 36198003 [TBL] [Abstract][Full Text] [Related]
22. Fiber-based HIC capture loop for coupling of protein A and size exclusion chromatography in a two-dimensional separation of monoclonal antibodies. Wang L; Trang HK; Desai J; Dunn ZD; Richardson DD; Marcus RK Anal Chim Acta; 2020 Feb; 1098():190-200. PubMed ID: 31948583 [TBL] [Abstract][Full Text] [Related]
23. Hydrophobic interaction chromatography for the characterization of monoclonal antibodies and related products. Fekete S; Veuthey JL; Beck A; Guillarme D J Pharm Biomed Anal; 2016 Oct; 130():3-18. PubMed ID: 27084526 [TBL] [Abstract][Full Text] [Related]
24. Investigation of anomalous charge variant profile reveals discrete pH-dependent conformations and conformation-dependent charge states within the CDR3 loop of a therapeutic mAb. Lan W; Valente JJ; Ilott A; Chennamsetty N; Liu Z; Rizzo JM; Yamniuk AP; Qiu D; Shackman HM; Bolgar MS MAbs; 2020; 12(1):1763138. PubMed ID: 32432964 [TBL] [Abstract][Full Text] [Related]
25. Five computational developability guidelines for therapeutic antibody profiling. Raybould MIJ; Marks C; Krawczyk K; Taddese B; Nowak J; Lewis AP; Bujotzek A; Shi J; Deane CM Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4025-4030. PubMed ID: 30765520 [TBL] [Abstract][Full Text] [Related]
26. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin. Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142 [TBL] [Abstract][Full Text] [Related]
27. Developability index: a rapid in silico tool for the screening of antibody aggregation propensity. Lauer TM; Agrawal NJ; Chennamsetty N; Egodage K; Helk B; Trout BL J Pharm Sci; 2012 Jan; 101(1):102-15. PubMed ID: 21935950 [TBL] [Abstract][Full Text] [Related]
28. Optimal charged mutations in the complementarity-determining regions that prevent domain antibody aggregation are dependent on the antibody scaffold. Perchiacca JM; Lee CC; Tessier PM Protein Eng Des Sel; 2014 Feb; 27(2):29-39. PubMed ID: 24398633 [TBL] [Abstract][Full Text] [Related]
29. Investigation of cathepsin D-mAb interactions using a combined experimental and computational tool set. Ranjan S; Chung WK; Hofele R; Heidbrink Thompson J; Bee J; Zhang L; Robbins D; Cramer SM Biotechnol Bioeng; 2019 Jul; 116(7):1684-1697. PubMed ID: 30882893 [TBL] [Abstract][Full Text] [Related]
30. Humanization of an anti-CD34 monoclonal antibody by complementarity-determining region grafting based on computer-assisted molecular modelling. Hou S; Li B; Wang L; Qian W; Zhang D; Hong X; Wang H; Guo Y J Biochem; 2008 Jul; 144(1):115-20. PubMed ID: 18424812 [TBL] [Abstract][Full Text] [Related]
31. Comparison of standard and new generation hydrophobic interaction chromatography resins in the monoclonal antibody purification process. Chen J; Tetrault J; Ley A J Chromatogr A; 2008 Jan; 1177(2):272-81. PubMed ID: 17709111 [TBL] [Abstract][Full Text] [Related]
32. Native Hydrophobic Interaction Chromatography Hyphenated to Mass Spectrometry for Characterization of Monoclonal Antibody Minor Variants. Wei B; Han G; Tang J; Sandoval W; Zhang YT Anal Chem; 2019 Dec; 91(24):15360-15364. PubMed ID: 31747256 [TBL] [Abstract][Full Text] [Related]
33. Cysteinylation of a monoclonal antibody leads to its inactivation. McSherry T; McSherry J; Ozaeta P; Longenecker K; Ramsay C; Fishpaugh J; Allen S MAbs; 2016; 8(4):718-25. PubMed ID: 27050640 [TBL] [Abstract][Full Text] [Related]
34. Identification and measurement of isoaspartic acid formation in the complementarity determining region of a fully human monoclonal antibody. Dick LW; Qiu D; Cheng KC J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(30):3841-9. PubMed ID: 19819766 [TBL] [Abstract][Full Text] [Related]
35. Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization. Maeso R; Huarte N; Julien JP; Kunert R; Pai EF; Nieva JL AIDS Res Hum Retroviruses; 2011 Aug; 27(8):863-76. PubMed ID: 21142698 [TBL] [Abstract][Full Text] [Related]
36. Process optimization and protein engineering mitigated manufacturing challenges of a monoclonal antibody with liquid-liquid phase separation issue by disrupting inter-molecule electrostatic interactions. Du Q; Damschroder M; Pabst TM; Hunter AK; Wang WK; Luo H MAbs; 2019; 11(4):789-802. PubMed ID: 30913985 [TBL] [Abstract][Full Text] [Related]
37. The effect of pH on antibody retention in multimodal cation exchange chromatographic systems. Robinson J; Roush D; Cramer SM J Chromatogr A; 2020 Apr; 1617():460838. PubMed ID: 31932086 [TBL] [Abstract][Full Text] [Related]
38. Cross-Interaction Chromatography-Based QSAR Model for Early-Stage Screening to Facilitate Enhanced Developability of Monoclonal Antibody Therapeutics. Kizhedath A; Karlberg M; Glassey J Biotechnol J; 2019 Aug; 14(8):e1800696. PubMed ID: 30810283 [TBL] [Abstract][Full Text] [Related]
39. Offline Coupling of Hydrophobic Interaction Chromatography-Capillary Zone Electrophoresis for Monitoring Charge-Based Heterogeneity of Recombinant Monoclonal Antibodies. Sarin D; Kumar S; Rathore AS Electrophoresis; 2024 Oct; ():. PubMed ID: 39402848 [TBL] [Abstract][Full Text] [Related]
40. Molecular surface descriptors to predict antibody developability: sensitivity to parameters, structure models, and conformational sampling. Park E; Izadi S MAbs; 2024; 16(1):2362788. PubMed ID: 38853585 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]